Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kineta Inc.
DescriptionSmall molecule antiviral with activity against Lassa fever virus and other arenaviruses
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationViral hemorrhagic fever
Indication DetailsViral hemorrhagic fever
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today